ArticleEnvironmental science and pollution research international2022
Bioaccumulation and toxicity effects of flubendiamide in zebrafish (Danio rerio).
Article in Environmental science and pollution research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 11 citations in OpenAlex.
- The price of protection: an integrated toxicological and modelling assessment of flubendiamide exposure in Anabas testudineus.Fish physiology and biochemistry · 2026Article
- Chlorantraniliprole (Coragen® 20% SC) exposure induced reproductive toxicity mediated by oxidative stress, apoptosis, and sperm quality deficient in male Wistar rats.Naunyn-Schmiedeberg's archives of pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Flubendiamide is a widely used diamide insecticide with many adverse effects on environmental organisms. This study assessed its bioaccumulation and toxicity effects in zebrafish (Danio rerio) using LC-MS/MS. The concentrations of flubendiamide in the whole zebrafish increased in the early stages and achieved steady levels at 14 days. The bioconcentration factors (BCFs) of flubendiamide was 1.125-2.011. Although flubendiamide did not significantly affect the growth phenotypes of zebrafish, it significantly changed the hepatic somatic index (HSI) of zebrafish. Histopathological analysis showed that flubendiamide could cause structural damage to the liver tissue of zebrafish. Further physiological and biochemical analysis showed that flubendiamide significantly changed the activity of catalase (CAT) and the contents of malondialdehyde (MDA) and glutathione (GSH) in liver of zebrafish. Moreover, flubendiamide significantly changed the mRNA expression levels of cell apoptosis-related genes, including p53, puma, caspase-3, caspase-9, apaf-1, and bax in liver of zebrafish. In summary, these results indicate that flubendiamide can cause liver damage by inducing oxidative stress and apoptosis in the liver of zebrafish. This study provides a background for further safety evaluation of flubendiamide to aquatic organisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.